PND47 CLADRIBINE TABLET, AS A DOMINANT COMPARATOR TO NATALIZUMAB IN HIGH-DISEASE ACTIVITY RELAPSING MULTIPLE SCLEROSIS PATIENTS, IN THE CONTEXT OF A DEVELOPING COUNTRY
| Autor: | Ayati, N., Fleifel, L., Sharifi, S., Sahraian, M.A., Nikfar, S. |
|---|---|
| Zdroj: | In Value in Health November 2019 22 Supplement 3:S745-S745 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect